Sarah L Cutrona1,2, Jessica G Golden3, Sarah L Goff4,5, Jessica Ogarek6, Bruce Barton7, Lloyd Fisher7,8, Peggy Preusse8, Devi Sundaresan8, Lawrence Garber3,8, Kathleen M Mazor7,3. 1. Veterans Health Administration, Bedford, MA, USA. Sarah.Cutrona@umassmed.edu. 2. University of Massachusetts Medical School, Worcester, MA, USA. Sarah.Cutrona@umassmed.edu. 3. Meyers Primary Care Institute, Worcester, MA, USA. 4. Baystate Medical Center, Springfield, MA, USA. 5. Tufts University School of Medicine, Boston, MA, USA. 6. Brown University, Providence, RI, USA. 7. University of Massachusetts Medical School, Worcester, MA, USA. 8. Reliant Medical Group, Worcester, MA, USA.
Abstract
BACKGROUND: Patient reminders for influenza vaccination, delivered via electronic health record (EHR) patient portal messages and interactive voice response (IVR) calls, offer an innovative approach to improving patient care. OBJECTIVE: To test the effectiveness of portal and IVR outreach in improving rates of influenza vaccination. DESIGN: Randomized controlled trial of EHR portal messages and IVR calls promoting influenza vaccination. PARTICIPANTS: Adults with no documented influenza vaccination 2 months after the start of influenza season (2014-2015). INTERVENTION: Using a factorial design, we assigned 20,000 patients who were active portal users to one of four study arms: (a) receipt of a portal message promoting influenza vaccines, (b) receipt of IVR call with similar content, (c) both a and b, or (d) neither (usual care). We randomized 10,000 non-portal users to receipt of IVR call or usual care. In all intervention arms, information on pneumococcal vaccination was included if the targeted patient was overdue for pneumococcal vaccine. MAIN MEASURES: EHR-documented influenza vaccination during the 2014-2015 influenza season, measured April 2015. KEY RESULTS: Among portal users, 14.0% (702) of those receiving both portal messages and calls, 13.4% (669) of message recipients, 12.8% (642) of call recipients, and 11.6% (582) of those with usual care received vaccines. On multivariable analysis of portal users, those receiving portal messages alone (OR 1.20, 95% CI 1.06-1.35) or IVR calls alone (OR 1.15 95% CI 1.02-1.30) were more likely than usual care recipients to be vaccinated. Those receiving both messages and calls were also more likely than the usual care group to be vaccinated (ad hoc analysis, using a Bonferroni correction: OR 1.29, 97.5% CI 1.13, 1.48). Among non-portal users, 8.5% of call recipients and 8.6% of usual care recipients received influenza vaccines (p = NS). Pneumococcal vaccination rates showed no significant improvement. CONCLUSIONS: Our outreach achieved a small but significant improvement in influenza vaccination rates. Registration: ClinicalTrials.gov Identifier NCT02266277 ( https://clinicaltrials.gov/ct2/show/NCT02266277 ).
RCT Entities:
BACKGROUND:Patient reminders for influenza vaccination, delivered via electronic health record (EHR) patient portal messages and interactive voice response (IVR) calls, offer an innovative approach to improving patient care. OBJECTIVE: To test the effectiveness of portal and IVR outreach in improving rates of influenza vaccination. DESIGN: Randomized controlled trial of EHR portal messages and IVR calls promoting influenza vaccination. PARTICIPANTS: Adults with no documented influenza vaccination 2 months after the start of influenza season (2014-2015). INTERVENTION: Using a factorial design, we assigned 20,000 patients who were active portal users to one of four study arms: (a) receipt of a portal message promoting influenza vaccines, (b) receipt of IVR call with similar content, (c) both a and b, or (d) neither (usual care). We randomized 10,000 non-portal users to receipt of IVR call or usual care. In all intervention arms, information on pneumococcal vaccination was included if the targeted patient was overdue for pneumococcal vaccine. MAIN MEASURES: EHR-documented influenza vaccination during the 2014-2015 influenza season, measured April 2015. KEY RESULTS: Among portal users, 14.0% (702) of those receiving both portal messages and calls, 13.4% (669) of message recipients, 12.8% (642) of call recipients, and 11.6% (582) of those with usual care received vaccines. On multivariable analysis of portal users, those receiving portal messages alone (OR 1.20, 95% CI 1.06-1.35) or IVR calls alone (OR 1.15 95% CI 1.02-1.30) were more likely than usual care recipients to be vaccinated. Those receiving both messages and calls were also more likely than the usual care group to be vaccinated (ad hoc analysis, using a Bonferroni correction: OR 1.29, 97.5% CI 1.13, 1.48). Among non-portal users, 8.5% of call recipients and 8.6% of usual care recipients received influenza vaccines (p = NS). Pneumococcal vaccination rates showed no significant improvement. CONCLUSIONS: Our outreach achieved a small but significant improvement in influenza vaccination rates. Registration: ClinicalTrials.gov Identifier NCT02266277 ( https://clinicaltrials.gov/ct2/show/NCT02266277 ).
Entities:
Keywords:
electronic health records; influenza vaccination; patient care
Authors: Alex H Krist; Steven H Woolf; Stephen F Rothemich; Robert E Johnson; J Eric Peele; Tina D Cunningham; Daniel R Longo; Ghalib A Bello; Gary R Matzke Journal: Ann Fam Med Date: 2012 Jul-Aug Impact factor: 5.166
Authors: Adam Wright; Eric G Poon; Jonathan Wald; Joshua Feblowitz; Justine E Pang; Jeffrey L Schnipper; Richard W Grant; Tejal K Gandhi; Lynn A Volk; Amy Bloom; Deborah H Williams; Kate Gardner; Marianna Epstein; Lisa Nelson; Alex Businger; Qi Li; David W Bates; Blackford Middleton Journal: J Gen Intern Med Date: 2011-09-09 Impact factor: 5.128
Authors: Deborah S Minor; Jennifer T Eubanks; Kenneth R Butler; Marion R Wofford; Alan D Penman; William H Replogle Journal: Am J Med Date: 2010-09-16 Impact factor: 4.965
Authors: Bevanne Bean-Mayberry; Elizabeth M Yano; Maria K Mor; Nichole K Bayliss; Xiangyan Xu; Michael J Fine Journal: J Am Geriatr Soc Date: 2009-06-08 Impact factor: 5.562
Authors: Peter G Szilagyi; Christina Albertin; Alejandra Casillas; Rebecca Valderrama; O Kenrik Duru; Michael K Ong; Sitaram Vangala; Chi-Hong Tseng; Cynthia M Rand; Sharon G Humiston; Sharon Evans; Michael Sloyan; Carlos Lerner Journal: JAMA Intern Med Date: 2020-07-01 Impact factor: 21.873
Authors: Nell J Marshall; Jennifer L Lee; Jessica Schroeder; Wei-Nchih Lee; Jermyn See; Mohammad Madjid; Mrudula R Munagala; John D Piette; Litjen Tan; Orly Vardeny; Michael Greenberg; Jan Liska; Monica Mercer; Sandrine Samson Journal: J Med Internet Res Date: 2022-10-07 Impact factor: 7.076
Authors: Lloyd Fisher; Matthew M Loiacono; Nick Payne; Tina Kelley; Michael Greenberg; Mary Charpentier; Candace Leblanc; Devi Sundaresan; Tim Bancroft; Andrea Steffens; Misti Paudel Journal: Influenza Other Respir Viruses Date: 2022-09-13 Impact factor: 5.606
Authors: Hassen Mohammed; Mark McMillan; Prabha H Andraweera; Salenna R Elliott; Helen S Marshall Journal: Hum Vaccin Immunother Date: 2021-10-08 Impact factor: 3.452
Authors: Jessica G Wijesundara; Mayuko Ito Fukunaga; Jessica Ogarek; Bruce Barton; Lloyd Fisher; Peggy Preusse; Devi Sundaresan; Lawrence Garber; Kathleen M Mazor; Sarah L Cutrona Journal: J Med Internet Res Date: 2020-09-25 Impact factor: 5.428
Authors: Peter G Szilagyi; Christina S Albertin; Alejandra Casillas; Rebecca Valderrama; O Kenrik Duru; Michael K Ong; Sitaram Vangala; Chi-Hong Tseng; Sharon G Humiston; Sharon Evans; Michael Sloyan; Jonathan E Bogard; Craig R Fox; Carlos Lerner Journal: J Gen Intern Med Date: 2021-09-01 Impact factor: 5.128